Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Altay Therapeutics has raised $37.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Altay Therapeutics's investors include Y Combinator, Sound Bioventures, HealthCap, Creative Destruction Lab, Pappas Capital.
Altay Therapeutics is headquartered in San Francisco, United States.
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Altay Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altay Therapeutics — Funding & Investors." VCBacked, October 14, 2026, https://www.vcbacked.co/company/altay-therapeutics. Accessed November 15, 2026.
VCBacked. (2026). Altay Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/altay-therapeutics
{{cite web |title=Altay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/altay-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Altay Therapeutics? Request a listing update